Latest Articles

Publication Date
Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test - BioSpace

Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test BioSpace

Published: March 31, 2026, 4:17 p.m.
Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test - The Joplin Globe

Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test The Joplin Globe

Published: March 31, 2026, 1:02 p.m.
Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test - joplinglobe.com

Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test joplinglobe.com

Published: March 31, 2026, 1:02 p.m.
Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test - Business Wire

Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test Business Wire

Published: March 31, 2026, 1 p.m.
Proteomic Analysis of Cervicovaginal Fluid for Diagnostic Endometriosis Biomarker Discovery.

Endometriosis is a prevalent inflammatory condition characterised by the presence of endometrial-like tissue outside the uterus and is associated with significant challenges, including diagnostic delays and continued reliance on laparoscopy. …

Published: March 31, 2026, midnight
ACOG Endometriosis Guidelines Target Diagnostic Delays.

Published: March 20, 2026, midnight
HerAnova Commercializes Blood Test for Endometriosis Detection, Targeting Years-Long Diagnostic Delays - R&D World

HerAnova Commercializes Blood Test for Endometriosis Detection, Targeting Years-Long Diagnostic Delays R&D World

Published: March 16, 2026, 9:31 p.m.
A SERRS-Based Lateral Flow Assay for Sensitive Detection of Mitochondrial DNA in Endometriosis Screening.

Endometriosis (EMT) is an incurable and painful chronic illness that affects approximately 10% of people assigned female at birth worldwide. Currently, EMT takes on average 5-7 years to diagnose after …

Published: March 12, 2026, midnight
Exosome-Enriched Hub Gene Networks Identify Diagnostic Biomarkers and Repurposable Therapeutic Targets in Endometriosis.

Endometriosis is a heterogeneous chronic inflammatory disorder associated with substantial diagnostic delay and limited therapeutic options, highlighting the need of robust non-invasive biomarkers and actionable molecular targets to complement existing …

Published: March 11, 2026, midnight
WOMEN'S HEALTH: Endometriosis awareness & reducing the diagnostic delay - FOX 17 West Michigan News

WOMEN'S HEALTH: Endometriosis awareness & reducing the diagnostic delay FOX 17 West Michigan News

Published: March 4, 2026, 12:38 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!